Octagon Capital Advisors LP 13D and 13G filings for Taysha Gene Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 6:05 pm Purchase |
2024-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA |
Octagon Capital Advisors LP | 10,450,000 5.100% |
10,450,000 (New Position) |
Filing |